The mechanistic Target of Rapamycin Complex 1 (mTORC1) is a major regulator of eukaryotic growth that coordinates anabolic and catabolic cellular processes with inputs such as growth factors and nutrients, including amino acids 1-3 . In mammals arginine is particularly important, promoting diverse physiological effects such as immune cell activation, insulin secretion, and muscle growth, largely mediated through activation of mTORC1 (refs 4-7). Arginine activates mTORC1 upstream of the Rag family of GTPases 8 , through either the lysosomal amino acid transporter SLC38A9 or the GATOR2-interacting Cellular Arginine Sensor for mTORC1 (CASTOR1) 9-12 . However, the mechanism by which the mTORC1 pathway detects and transmits this arginine signal has been elusive. Here, we present the 1.8 Å crystal structure of arginine-bound CASTOR1. Homodimeric CASTOR1 binds arginine at the interface of two Aspartate kinase, Chorismate mutase, TyrA (ACT) domains, enabling allosteric control of the adjacent GATOR2-binding site to trigger dissociation from GATOR2 and downstream activation of mTORC1. Our data reveal that CASTOR1 shares substantial structural homology with the lysine-binding regulatory domain of prokaryotic aspartate kinases, suggesting that the mTORC1 pathway exploited an ancient, amino-acid-dependent allosteric mechanism to acquire arginine sensitivity. Together, these results establish a structural basis for arginine sensing by the mTORC1 pathway and provide insights into the evolution of a mammalian nutrient sensor.
Extended Data Fig. 2b ). This finding indicates that CASTOR1 must be dimeric to robustly inhibit GATOR2 upon arginine starvation.
CASTOR1 binds arginine through a narrow pocket at the interface of ACT2 and ACT4, distal to the dimerization interface ( Fig. 1a, 2a, b) . The side chain of arginine projects towards the β15 loop, a loop connecting β15 and β16, where the backbone carbonyls of Thr300, Phe301, and Phe303 coordinate the guanidinium group of arginine ( Fig. 2a ). Immediately adjacent to the β15 loop, the anionic side chain of Asp304 forms an additional stabilizing salt bridge with the cationic arginine side chain ( Fig. 2a ). On the opposite side of the pocket, the hydroxyl side chain of Ser111 and the backbone carbonyl of Val112 in the α3 loop anchor the free amino group of arginine in place, while the free carboxyl group points towards a water-filled cavity that separates it from ACT2 ( Fig. 2a, b ). Mutation of either Ser111 or Asp304 (S111A, D304A) abolished the arginine-binding ability of CASTOR1 in vitro, highlighting the critical role of these contacts in arginine sensing by CASTOR1 ( Fig. 2c ). Furthermore, when expressed in HEK-293T cells, these mutants bound constitutively to GATOR2 and strongly inhibited mTORC1 signalling even in the presence of arginine ( Fig. 2d ).
Together, these data explain the molecular determinants of specificity in the CASTOR1-arginine interaction. While Ser111 fixes the position of the free amine, the location of the β15 loop and Asp304 sets a strict length requirement for the bound ligand (Extended Data Fig. 3a ). In addition, the positions of the three hydrogen-bond-donating nitrogen atoms in the guanidinium group facilitate contacts with both the carbonyl oxygen atoms in the β15 loop and the side chain of Asp304 ( Fig. 2a ). Finally, the gap behind the free carboxyl group of arginine suggests that CASTOR1 can tolerate ligands with modifications to that functional group (Fig. 2b) . We tested these predictions by investigating the ability of various arginine analogues to disrupt the CASTOR1-GATOR2 interaction in vitro ( Fig. 2e and Extended Data Fig. 3b ). Consistent with our structural analysis, while the carboxy-modified arginine-methyl ester triggered full dissociation of CASTOR1 from GATOR2, compounds with alterations to the guanidinium group, α-amine, or the length of the side chain had no effect.
In addition to the main pocket contacts described above, a highly conserved, glycine-rich loop connecting β14 and α7 in ACT4 (β14 loop, residues 269-280) wraps over the arginine pocket, fully burying the bound ligand (Figs 2a, 3a and Extended Data Fig. 1a ). The β14 loop forms several hydrogen bonds with arginine through the backbone amides of Gly279 and Ile280, as well as the backbone oxygen atoms of Gly274 and Glu277 (Figs 2a, 3a) . The ordered conformation of the β14 loop also places it just along the ACT2-ACT4 interface, enabling it to form several intramolecular contacts with residues in ACT2 ( Fig. 3a ). Cys278 forms hydrogen bonds with the backbones of Val110 and S111 in the α3 loop, while Asp276 forms a salt bridge with Arg126. In addition, Glu277 extends in the opposite direction to form another salt bridge with His175 ( Fig. 3a) . Thus, the β14 loop facilitates Letter reSeArCH the formation of numerous inter-ACT-domain contacts in the presence of arginine. Indeed, the arginine and β14 loop contribute about 40% of the total buried surface area in the ACT2-ACT4 interface of the arginine-bound structure (390 Å 2 out of 980 Å 2 ).
The glycine-rich β14 loop is predicted to have a high propensity for disorder. Our structure suggests that these inter-ACT-domain contacts could stabilize it in an ordered conformation over the bound arginine.
Indeed, mutation of key residues in both the β14 loop (D276A, E277A, C278A) and the adjacent ACT domains (R126A, H175A) significantly reduced the arginine-binding capacity of CASTOR1 (Fig. 3b, c) , indicating that the inter-ACT-domain contacts formed by the β14 loop are required for arginine sensing by CASTOR1. In addition, we found that the N-terminal (ACT1 and ACT2) and C-terminal (ACT3 and ACT4) halves of CASTOR1 associated in both an arginine-and Two orthogonal views of the CASTOR1  homodimer (ribbon diagram) , with ACTdomains 1-4 coloured in green, purple, wheat, and pink, respectively. The bound arginine is shown in yellow. Disordered regions not observed in the crystal structure are omitted. b, View of the CASTOR1 dimerization interface, with side chains of key residues represented in stick form. c, Dimerization-deficient CASTOR1 Y207S and I202E mutants display weaker interactions with endogenous GATOR2. HEK-293T cells transiently expressing FLAG-tagged CASTOR1 wild type (WT) and the indicated haemagglutinin (HA)-tagged constructs were starved of arginine for 50 min and, where indicated, re-stimulated for 10 min. HA-immunoprecipitates were generated from cell lysates and analysed by immunoblotting for the indicated proteins. Mios was used as a representative GATOR2 component. loop (residues 269-280) is omitted for clarity. c, CASTOR1 S111A and D304A mutants do not bind arginine in vitro. FLAG-immunoprecipitates prepared from HEK-293T cells transiently expressing the indicated FLAG-tagged proteins were used in binding assays with [ 3 H]arginine as described in the Methods. Values are mean ± s.d. for three technical replicates from one representative experiment. d, The CASTOR1 S111A and D304A mutants constitutively bind GATOR2 and inhibit mTORC1 signalling in cells. HEK-293T cells transiently expressing FLAG-S6K1 and the indicated HA-tagged constructs were starved of arginine for 50 min and, where indicated, re-stimulated for 10 min. Both FLAG-and HAimmunoprecipitates were prepared from lysates and analysed as in Fig. 1c . e, Effects of various arginine analogues on the CASTOR1-GATOR2 interaction in vitro. HEK-293T cells transiently expressing wild-type HA-CASTOR1 were starved of arginine for 50 min. HA-immunoprecipitates were prepared from cell lysates then incubated with 400 μM of the indicated compounds for 20 min and analysed as in Fig. 1c .
β14-loop-dependent manner when expressed as separate polypeptides in HEK-293T cells 12 (Fig. 3d ), indicating that arginine probably induces a conformational change in CASTOR1 by stabilizing the ACT2-ACT4 interaction.
In addition to CASTOR1, human cells express a related protein, CASTOR2, which shares 63% sequence identity with CASTOR1 but does not bind arginine 12 . Although the regions of CASTOR1 that are directly involved in arginine binding are well conserved (Extended Data Fig. 1a ), we identified residues along the ACT2-ACT4 interface (His108 to Val110) that differ between CASTOR1 and CASTOR2 (Extended Data Fig. 4a ). Replacing these residues in CASTOR1 with those from CASTOR2 abrogated arginine binding in vitro and converted CASTOR1 to a nearly-constitutive GATOR2-interactor in cells, resembling CASTOR2 (Extended Data Fig. 4b-d ). Notably, these residues immediately precede Ser111 and form a hydrogen bond with Cys278 in the β14 loop ( Fig. 3a and Extended Data Fig. 4a ), suggesting that their identity may be critical for the proper positioning of the α3 loop to enable arginine binding and/or the association of ACT2 and ACT4. The corresponding mutation in CASTOR2 (QNI108-110HHV), however, was not sufficient to confer arginine-binding ability, suggesting that additional amino acid differences also contribute to this functional difference (Extended Data Fig. 4d ).
To understand how arginine induces dissociation of CASTOR1 from GATOR2, we identified five highly conserved sites in CASTOR1 that are required for its interaction with GATOR2 (Y118, Q119, D121, E261 and D292; Fig. 4a and Extended Data Fig. 1a ). Importantly, these mutants still bind arginine in vitro and homodimerize when expressed in cells (Extended Data Fig. 5a, b ). Notably, these residues cluster along the surface of the ACT2-ACT4 interface, adjacent to the arginine-binding pocket but on the opposite face of the protein (Fig. 4b, c ). Glu261 and Asp292 are closely linked to the β14 loop, separated only by β14 and α7, respectively ( Fig. 4c ). Furthermore, the critically important residue Asp121 is buried in the ACT2-ACT4 interface, potentially explaining why the arginine-bound conformation of CASTOR1 does not interact with GATOR2 ( Fig. 4c ).
Together, these results suggest a model in which arginine binding arranges the glycine-rich β14 loop in a conformation that enables the intramolecular association of ACT2 and ACT4 ( Fig. 3a-d ). The association of these domains would alter the position and exposure of the residues required for GATOR2 binding, which also lie along the ACT2-ACT4 interface ( Fig. 4a-c) , thereby triggering the dissociation of CASTOR1 from GATOR2 and the subsequent activation of mTORC1 (Fig. 4e ).
The observation that CASTOR1 inhibits mTORC1 signalling and interacts with GATOR2 in an arginine-sensitive manner suggests that CASTOR1 may regulate mTORC1 by inhibiting GATOR2, a mechanism analogous to that of the recently identified leucine sensor Sestrin2 (refs [16] [17] [18] [19] . Using our GATOR2-binding-deficient mutants, we were able to test this hypothesis directly. In contrast to wild-type CASTOR1, the GATOR2-binding-deficient YQ118-119AA and D121A mutants both failed to inhibit mTORC1 signalling in cells ( Fig. 4d ). Moreover, owing to their ability to dimerize with endogenous CASTOR1, these mutants also functioned as dominant negatives, rendering mTORC1 fully resistant to arginine starvation ( Fig. 4d ). Thus, the CASTOR1-GATOR2 interaction is required to signal arginine deprivation to mTORC1.
Although defined by their common topology, ACT domains are highly diverse in sequence and form a wide range of structural assemblies 14, 15 . Comparison of our structure with other ACT-domaincontaining proteins in the Protein Data Bank (PDB) revealed that CASTOR1 shares substantial structural homology with the allosteric regulatory domains of bacterial aspartate kinases, including those found in Escherichia coli (AKeco) and cyanobacteria (AKsyn) 20,21 ( Fig. 5a and Extended Data Fig. 6a ). Aspartate kinases catalyse the first step of a metabolic pathway that synthesizes several amino acids, including lysine, and display allosteric feedback inhibition when downstream products bind to their regulatory domains 22 . Notably, AKeco binds lysine through pockets that bear a striking resemblance to the arginine-binding pocket of CASTOR1 20 (Fig. 5b ). Furthermore, AKeco residues Arg305, Glu346, and Val347, which correspond to the positions of the critical GATOR2-binding residues Glu261, Tyr118, and Gln119, respectively, participate directly in the lysine-dependent inhibition of the kinase domain in AKeco 20 (Extended Data Fig. 6b ). Thus, the overall structure, mode of amino-acid binding and likely allosteric C278A mutants constitutively bind GATOR2 in cells. HEK-293T cells transiently expressing the indicated HA-tagged constructs were starved of arginine for 50 min and, where indicated, re-stimulated for 10 min. HA-immunoprecipitates were prepared and analysed as in Fig. 1c . d, CASTOR1 ACT1-2 (residues 1-169) and CASTOR1 ACT3-4 (169-329) associate in an arginine-and β14-loop-dependent manner. HEK-293T cells transiently expressing the indicated HA-tagged constructs were starved of arginine for 60 min and, where indicated, re-stimulated for 60 min. HA-immunoprecipitates were prepared and analysed as in Fig. 1c . mechanism of CASTOR1 all resemble those found in the regulatory domains of prokaryotic aspartate kinases.
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These similarities suggest that CASTOR1 shares an evolutionary origin with prokaryotic aspartate kinases. Aspartate kinases are found throughout the bacteria, archaea, and many eukaryotic lineages, but were lost before the emergence of metazoa, whereas CASTOR1 homologues are present only in metazoa (Fig. 5c ). Thus, in order to acquire arginine sensitivity in early multicellular animals, the mTORC1 pathway may have taken advantage of this more ancient, lysine-sensitive regulatory mechanism (Fig. 5d ). This exploitation of a pre-existing allosteric module is analogous to the models proposed for the evolution of hormone-receptor signalling 23 and yeast MAP kinases 24 , and may enable the more rapid incorporation of novel signalling responses into existing pathways 25 .
Together, our results provide a structural basis for arginine sensing by the mTORC1 pathway. Furthermore, our data obtained using arginine Figure 4 | The GATOR2 binding site of CASTOR1 is at the ACT2-ACT4 interface and is required for signalling arginine deprivation to mTORC1. a, The CASTOR1 D292A, E261A, D121A, and YQ118-119AA mutants are deficient in GATOR2 binding. HA-immunoprecipitates prepared from arginine-starved HEK293T-cells transiently expressing the indicated HA-tagged constructs were analysed as in Fig. 1c . b, Solventexposed surface view of the CASTOR1 homodimer highlighting the GATOR2-binding sites (red). Residue E261 is in a partially disordered loop and not visible in one monomer (left). c, Cross-sectional view of the ACT2-ACT4 interface showing the positions of the critical GATOR2binding residues relative to the bound arginine (yellow) and the β14 loop. d, The GATOR2-binding-deficient YQ118-119AA and D121A mutants of CASTOR1 fail to inhibit the mTORC1 pathway and render cells insensitive to arginine starvation. HEK-293T cells were transiently transfected with FLAG-S6K1 and the indicated HA-tagged constructs. FLAGimmunoprecipitates were prepared and analysed as in Fig. 1d . e, A model of how arginine releases CASTOR1 from GATOR2 to activate mTORC1. 
Lysine arginine sensitivity
analogues suggest that our structure may be useful for predicting compounds that can modulate arginine sensing by CASTOR1 in vivo. As the deregulation of mTORC1 is common in a number of human diseases, including cancer 26, 27 , the identification of novel pharmacological regulators of mTORC1 activity is of particular interest.
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Materials. Reagents were obtained from the following sources: HRP-labelled anti-rabbit secondary antibody from Santa Cruz Biotechnology; antibodies to phospho-T389 S6K1, S6K1, Mios and the FLAG epitope from Cell Signalling Technology; antibodies to the haemagglutinin epitope from Bethyl laboratories; antibody to raptor from Millipore. All antibodies used have been published previously 12, 19 . FLAG-M2 affinity gel and amino acids from Sigma Aldrich; RPMI without leucine, arginine, or lysine from Pierce; DMEM from SAFC Biosciences; XtremeGene9 and Complete Protease Cocktail from Roche; inactivated fetal calf serum (IFS) from Invitrogen; [ 3 H]-labelled arginine from American Radiolabelled Chemicals. Protein production and purification. Full-length, codon-optimized human CASTOR1 was N-terminally fused with a human rhinovirus 3C protease-cleavable His 10 -Arg 8 -ScSUMO tag and cloned into a pET-Duet-1 bacterial expression vector. This vector was transformed into E. coli LOBSTR (DE3) cells (Kerafast) 28 . Cells were grown at 37 °C to 0.6 optical density (OD), then protein production was induced with 0.2 mM IPTG at 18 °C for 12-14 h. Cells were collected by centrifugation at 6,000g, re-suspended in lysis buffer (50 mM potassium phosphate, pH 8.0, 500 mM NaCl, 30 mM imidazole, 3 mM β-mercaptoethanol (βME) and 1 mM PMSF) and lysed with a cell disruptor (Constant Systems). The lysate was cleared by centrifugation at 10,000g for 20 min. The soluble fraction was incubated with Ni-Sepharose 6 Fast Flow beads (GE Healthcare) for 30 min on ice. After washing of the beads with lysis buffer, the protein was eluted in 250 mM imidazole, pH 8.0, 150 mM NaCl and 3 mM βME. The Ni eluate was diluted 1:1 with 10 mM potassium phosphate, pH 8.0, 0.1 mM EDTA and 1 mM dithiothreitol (DTT), and was subjected to cation-exchange chromatography on a 5 ml SP sepharose fast flow column (GE Healthcare) with a linear NaCl gradient. The eluted CASTOR1 was then incubated with 3C protease and dialysed overnight at 4 °C into 10 mM potassium phosphate, pH 8.0, 150 mM NaCl, 0.1 mM EDTA and 1 mM DTT, followed by a second cation-exchange chromatography run on an SP Sepharose Fast Flow column (GE Healthcare) with a linear NaCl gradient. The protein was further purified via size-exclusion chromatography on a Superdex S200 16/60 column (GE Healthcare) equilibrated in running buffer (10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.1 mM EDTA and 1 mM DTT). Selenomethionine (SeMet)-derivatized CASTOR1 was prepared as described previously 29 and purified as the native version, except that the reducing-agent concentration (βME and DTT) was 5 mM in all buffers. Crystallization. Purified CASTOR1 was concentrated to 6 mg/ml and incubated in 2 mM arginine for >1 h before setting crystal trays. Crystals were grown at 18 °C by hanging-drop vapour diffusion with 1 μl of protein at 6 mg/ml mixed with an equal volume of reservoir solution containing 0.1 M sodium acetate pH 5.0, 0.25 M ammonium acetate, and 22.5% PEG 3350. Selenomethionine-derivatized CASTOR1 was crystallized in 0.1 M BIS-TRIS pH 5.6, 0.25 M ammonium acetate, and 22.5% PEG3350. Crystals were cryoprotected in mother liquor supplemented with 20% (v/v) ethylene glycol. Data collection and structure determination. Data collection was performed at the Advanced Photon Source end station 24-IDC at Argonne National Laboratory, at 100 K. All data-processing steps were carried out with programs provided through SBgrid 30 . Data reduction was performed with HKL2000 31 . A complete native data set was collected to 1.8 Å (at wavelength 0.9792 Å) and a complete SeMet data set, at the selenium peak wavelength (0.9792 Å), was collected to 2.2 Å. The phase problem was solved using single-wavelength anomalous dispersion (SAD) and selenium positions were determined in HySS, run as part of the PHENIX AutoSol program 32 , for the SeMet data set (space group P2 1 , 4 molecules per asymmetric unit). An interpretable 2.2 Å experimental electron density map was obtained, and manual model building was carried out in Coot 33 . Subsequent refinement was carried out with the superior 1.8 Å native data set using phenix. refine to a final R work /R free of 17.2%/20.4%. Ramachandran statistics in the final model are 99% favoured, 1% allowed, and 0% outlier. Structural analysis. Protein-protein and protein-ligand interfaces were analysed using PDBePISA 34 . NCBI's Vector Alignment Search Tool (VAST) 35 was used to identify structurally related proteins in the PDB. The multiple sequence alignment (MSA) was generated in Jalview 36 with the T-Coffee alignment algorithm 37 . Sequences of CASTOR1 homologues were obtained via NCBI BLAST searches 38 . All structure figures were made in PyMol 39 . Cell lysis and immunoprecipitation. Cells were rinsed once with ice-cold PBS and immediately lysed with Triton lysis buffer (1% Triton, 10 mM β-glycerol phosphate, 10 mM pyrophosphate, 40 mM HEPES pH 7.4, 2.5 mM MgCl 2 and 1 tablet of EDTA-free protease inhibitor (Roche) (per 25 ml buffer). The cell lysates were cleared by centrifugation at 13,000 rpm at 4 °C in a microcentrifuge for 10 min. For anti-HA-immunoprecipitations, the magnetic anti-HA beads (Pierce) were washed three times with lysis buffer. 30 μl of a 50/50 slurry of the affinity gel was then added to clarified cell lysates and incubated with rotation for 1 h at 4 °C.
Following immunoprecipitation, the beads were washed four times with lysis buffer containing 500 mM NaCl. Immunoprecipitated proteins were denatured by the addition of 50 μl of sample buffer and boiling for 5 min as described 40 , resolved by 8-16% SDS-PAGE, and analysed by immunoblotting.
For co-transfection experiments in HEK-293T cells, 2.5 million cells were plated in 10 cm culture dishes. Twenty-four hours later, cells were transfected using the polyethylenimine method 41 with the pRK5-based cDNA expression plasmids indicated in the following amounts: 50 ng CASTOR1-HA (wild-type or mutant), 50 ng CASTOR1-FLAG, 1 μg HA-metap2, or 2 ng S6K. For in vitro dissociation experiments, 50 ng of wild-type CASTOR1-HA was transfected into HEK-293T cells. The total amount of plasmid DNA in each transfection was normalized to 5 μg with empty pRK5. 36-48 h after transfection, cells were lysed as described above.
For experiments that required amino acid starvation or re-stimulation, cells were treated as previously described 42 . Briefly, cells were incubated in arginine-free RPMI for 50 min and then re-stimulated with 500 μM arginine for 10 min. Arginine binding assay. Five million HEK-293T cells were plated on a 15 cm plate four days before the experiment. Twenty-four hours after plating, the cells were transfected via the polyethylenimine method with the pRK5-based cDNA expression plasmids indicated in the figures in the following amounts: 15 μg FLAG-Rap2A, 500 ng FLAG-CASTOR1 (wild-type or mutant). The total amount of plasmid DNA in each transfection was normalized to 15 μg total DNA with empty PRK5. Forty-eight hours after transfection cells were lysed as previously described. If multiple samples of the same type were represented in the experiment, the cell lysates were combined, mixed, and evenly distributed amongst the relevant tubes.
Anti-FLAG beads were blocked by rotating in 1 μg/μl bovine serum albumin (BSA) for 20 min at 4 °C, then washed twice in lysis buffer and re-suspended in an equal volume of lysis buffer. 30 μl of bead slurry was added to each of the clarified cell lysates and incubated as previously described. After immunoprecipitation, the beads were washed as previously and incubated for one hour on ice in cytosolic buffer (0.1% Triton, 40 mM HEPES pH 7.4, 10 mM NaCl, 150 mM KCl, 2.5 mM MgCl 2 ) with the appropriate amount of [ 3 H]-labelled arginine and cold arginine. At the end of one hour, the beads were aspirated dry and rapidly washed three times with cytosolic buffer. The beads were aspirated dry again and resuspended in 85 μl of cytosolic buffer. Each sample was mixed well and three 10 μl aliquots were quantified separately using a TriCarb scintillation counter (PerkinElmer). This process was repeated in pairs for each sample, to ensure similar incubation and wash times for all samples analysed across different experiments. In vitro CASTOR1-GATOR2 dissociation assay with arginine analogues. HEK-293T were transfected with HA-CASTOR1 constructs as described above. 48 h after transfection, cells were starved for all amino acids for 50 min, lysed and subjected to anti-FLAG immunoprecipitation as described previously. The CASTOR1-GATOR2 complexes immobilized on the haemagglutinin beads were washed twice in lysis buffer with 500 mM NaCl, then incubated for 20 min in 1 ml of cytosolic buffer with 400 μM of the indicated compound. The amount of GATOR2 and CASTOR1 that remained bound was assayed by SDS-PAGE and immunoblotting as described previously. Cell lines and tissue culture. HEK-293T cells were maintained at 37 °C and 5% CO2 and cultured in DMEM 10% IFS supplemented with 2 mM glutamine, penicillin (100 IU/ml) and streptomycin (100 μg/ml). HEK-293T cells were obtained from the American Type Culture Collection (ATCC) and were free of mycoplasma contamination. Statistical analysis. For the arginine-binding assays, two-tailed t-tests were used for comparison between two groups. All comparisons were two-sided, and P values of less than 0.005 were considered statistically significant. The data meet the assumptions of the test and the variance is similar between groups that are being statistically compared. No statistical methods were used to predetermine sample size. The experiments were not randomized. The investigators were not blinded to allocation during experiments and outcome assessment. Structural evidence for common ancestry of the nuclear pore complex and vesicle coats. Science 322, 1369-1373 (2008 for three technical replicates from one representative experiment. b, Dimerization-deficient CASTOR1 Y207S and I202E mutants fail to inhibit mTORC1. HEK-293T cells transiently expressing FLAG-S6K1 and HA-tagged wild-type, Y207S, or I202E CASTOR1 were starved of arginine for 50 min and, where indicated, re-stimulated for 10 min. FLAGimmunoprecipitates were prepared from lysates and analysed as in Fig. 1c . Phospho-S6K1 was used as an indicator of mTORC1 activity. and CASTOR2, highlighting differences in amino acid sequence that are in close proximity to arginine-binding residues in CASTOR1. b, The CASTOR1 HHV108-110QNI mutant constitutively binds GATOR2 in cells. HEK-293T cells transiently expressing HA-metap2 or the indicated HA-tagged CASTOR1 constructs were starved of arginine for 50 min and, where indicated, re-stimulated for 10 min. HA-immunoprecipitates were prepared and analysed as in Fig. 1c . c, The CASTOR1 HHV108-110QNI mutant displays reduced arginine-binding capacity in vitro. Binding assays were performed with the indicated CASTOR1 or CASTOR2 constructs and immunoprecipitates analysed as in Fig. 2c . Values are mean ± s.d. for three technical replicates from one representative experiment. d, Comparison of the CASTOR1 HHV108-110QNI mutant and wild-type CASTOR2. HEK-293T cells transiently expressing HA-metap2 or the indicated HA-tagged CASTOR1 or CASTOR2 constructs were starved of arginine for 50 min and, where indicated, re-stimulated for 10 min. HA-immunoprecipitates were prepared and analysed as in Fig. 1c . included as a competitor where indicated. Values are mean ± s.d. for three technical replicates from one representative experiment. b, The CASTOR1 YQ118-119AA, D121A, E261A and D292A mutants dimerize in cells. HA-immunoprecipitates prepared from HEK293T-cells transiently expressing CASTOR1-FLAG and HA-metap2 or the indicated HA-tagged CASTOR1 constructs were analysed as in Fig. 1c .
Letter reSeArCH
